Pfizer has announced the availability of attention deficit hyperactivity disorder (ADHD) therapy, Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension, in the US. The extended-release liquid ...
Tags: Pfizer, ADHD therapy, Quillivant XR CII